Contribution à l’optimalisation du traitement des tendinopathies chroniques :injection de concentrés plaquettaires chez des patients présentant une tendinopathie rotulienne supérieureOptimization of the treatment of the chronic tendinopathies: injection of platelet-rich plasma among patients with a jumper's knee

Phase 1

• Conditions: Jumper's knee or patellar tendinopathy

• Registration Number: EUCTR2010-021957-38-BE
• Lead Sponsor: CHU Liège - Physical Medicine Service

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-07-20
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

unilateral jumper's knee rebel to classic traetment
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

traumatic lesion in the knee (bilaterally)
ACL rupture
muscle tears

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: To observe effects of platelet-rich plasma (PRP) on the healing process of jumper's knee.;Secondary Objective: To observe decrease of pain after injectyion of PRP;Primary end point(s): Standardization of the treatment of tendinoapthy with PRP injection.